These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 2990722)

  • 1. Estrogen changes as a critical factor in modulation of central opioid tonus: possible correlations with post-menopausal migraine.
    Genazzani AR; Petraglia F; Volpe A; Facchinetti F
    Cephalalgia; 1985 May; 5 Suppl 2():212-4. PubMed ID: 2990722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transient failure of central opioid tonus and premenstrual symptoms.
    Facchinetti F; Martignoni E; Sola D; Petraglia F; Nappi G; Genazzani AR
    J Reprod Med; 1988 Jul; 33(7):633-8. PubMed ID: 3050071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of estrogen-progestin replacement therapy on plasma beta-endorphin levels in menopausal women.
    Ortega E; Cuadros JL; Gonzalez AR; Ruiz E
    Biochem Mol Biol Int; 1993 Apr; 29(5):831-6. PubMed ID: 8508135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of central opioid tonus in menstrual migraine.
    Petraglia F; Martignoni E; Sola D; Cicoli C; Facchinetti F; Nappi G; Genazzani AR
    Cephalalgia; 1983 Aug; 3 Suppl 1():98-100. PubMed ID: 6311427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex hormones and headache.
    Silberstein SD
    Rev Neurol (Paris); 2000; 156 Suppl 4():4S30-41. PubMed ID: 11139745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Migraine, menopause and hormonal replacement therapy.
    Silberstein SD; de Lignières B
    Cephalalgia; 2000 Apr; 20(3):214-21. PubMed ID: 10997776
    [No Abstract]   [Full Text] [Related]  

  • 7. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone.
    Rapkin AJ; Shoupe D; Reading A; Daneshgar KK; Goldman L; Bohn Y; Brann DW; Mahesh VB
    J Soc Gynecol Investig; 1996; 3(2):93-8. PubMed ID: 8796815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that estrogens inhibit LH secretion through opioids in postmenopausal women using naloxone.
    Melis GB; Paoletti AM; Gambacciani M; Mais V; Fioretti P
    Neuroendocrinology; 1984 Jul; 39(1):60-3. PubMed ID: 6087184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The treatment of women with climacteric symptoms with emphasis on perimenopausal hormone therapy].
    Bogchelman DH; Lappöhn RE; Janssens J
    Ned Tijdschr Geneeskd; 1979 Jun; 123(25):1072-5. PubMed ID: 223071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term effects of ovariectomy: the opioid control of LH secretion in fertile climacteric and postmenopausal women.
    Petraglia F; Comitini G; D'Ambrogio G; Volpe A; Facchinetti F; Alessandrini G; Genazzani AR
    J Endocrinol Invest; 1985 Aug; 8(4):325-30. PubMed ID: 2999209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A two-year, double-blind comparison of estrogen-androgen and conjugated estrogens in surgically menopausal women. Effects on bone mineral density, symptoms and lipid profiles.
    Barrett-Connor E; Young R; Notelovitz M; Sullivan J; Wiita B; Yang HM; Nolan J
    J Reprod Med; 1999 Dec; 44(12):1012-20. PubMed ID: 10649811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of oestrogen and progesterone on fasting serum cholesterol and triglyceride levels in post-menopausal women.
    Varma TR; Morsman J
    Int J Gynaecol Obstet; 1982 Apr; 20(2):91-7. PubMed ID: 6125443
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormonal treatment of the menopause and vascular pathology].
    Rozenbaum H
    J Mal Vasc; 1984; 9 Suppl A():32-4. PubMed ID: 6330256
    [No Abstract]   [Full Text] [Related]  

  • 14. Painful and non-painful effects of low doses of morphine in migraine sufferers partly depend on excitatory amino acids and gamma-aminobutyric acid.
    Nicolodi M
    Int J Clin Pharmacol Res; 1998; 18(2):79-85. PubMed ID: 9675625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do estradiol levels influence on the cognitive function during antidepressant treatments in post-menopausal women with major depressive disorder? A comparison with pre-menopausal women.
    Pae CU; Mandelli L; Han C; Ham BJ; Masand PS; Patkar AA; Steffens DC; De Ronchi D; Serretti A
    Neuro Endocrinol Lett; 2008 Aug; 29(4):500-6. PubMed ID: 18766158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adequate reduction degree of pituitary gonadotropin levels in the clinical management of short-term hormone replacement therapy of women with menopausal symptoms.
    Ushiroyama T; Sakuma K; Ikeda A; Ueki M
    J Med; 2004; 35(1-6):281-94. PubMed ID: 18084886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal management of migraine at menopause.
    Nappi RE; Sances G; Detaddei S; Ornati A; Chiovato L; Polatti F
    Menopause Int; 2009 Jun; 15(2):82-6. PubMed ID: 19465675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of oral and transdermal hormone replacement therapy on internal carotid artery pulsatility indices in postmenopausal women. A prospective, randomized, comparative study.
    Sendağ F; Terek MC; Karadadaş N; Bilgin O
    J Reprod Med; 2001 Nov; 46(11):962-8. PubMed ID: 11762152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Episodic secretion of LH and FSH after ovariectomy. Secretory patterns in response to estrogen and progesterone.
    Wallach EE; DeCherney AH; Russ D; Duckett G; Garcia CR; Root AW
    Obstet Gynecol; 1973 Feb; 41(2):227-33. PubMed ID: 4684207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The lowering of lipoprotein[a] induced by estrogen plus progesterone replacement therapy in postmenopausal women.
    Soma MR; Osnago-Gadda I; Paoletti R; Fumagalli R; Morrisett JD; Meschia M; Crosignani P
    Arch Intern Med; 1993 Jun; 153(12):1462-8. PubMed ID: 8390232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.